ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,738.52
-1.78%
US Tech 100
19,620.80
-2.29%
다우존스 지수
42,579.08
-0.99%
Bitcoin
87,893.29
-2.27%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Cartesian Therapeutics Inc (RNAC) 시세

Cartesian Therapeutics Inc

Cartesian Therapeutics Inc (RNAC)

NASDAQ
17.85
-0.07
(-0.39%)
마감 07 3월 6:00AM
15분 지연
17.85
0.18
(1.02%)
시간외 거래: 7:16AM
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
17.85
매수가
17.41
매도가
19.14
거래량
29,579
17.48 일간 변동폭 17.98
11.665 52주 범위 41.87
market_cap
453.656M
전일 종가
17.92
개장가
17.59
최근 거래 시간
1
@
17.85
마지막 거래 시간
재정 규모
US$ 524,623
VWAP
17.7363
평균 볼륨(3m)
97,499
발행 주식
25,414,898
배당수익률
-
주가수익률
-2.04
주당순이익(EPS)
-8.64
매출
26M
순이익
-219.71M

Cartesian Therapeutics Inc 정보

Cartesian Therapeutics, Inc. is a clinical-stage company. The Company is engaged in developing messenger ribonucleic acids (mRNA) cell therapies for the treatment of autoimmune diseases. It is leveraging its proprietary technology and manufacturing platform, RNA Armory, to develop mRNA cell therapie... Cartesian Therapeutics, Inc. is a clinical-stage company. The Company is engaged in developing messenger ribonucleic acids (mRNA) cell therapies for the treatment of autoimmune diseases. It is leveraging its proprietary technology and manufacturing platform, RNA Armory, to develop mRNA cell therapies for autoimmune diseases. Its lead asset e, Descartes-08, is an autologous mRNA chimeric antigen receptor T-cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), that the Company is developing for the treatment of autoimmune diseases. Descartes-08 is in Phase II clinical development. Descartes-15 is a next-generation, autologous anti-BCMA mRNA CAR-T. Using its proprietary technology and manufacturing platform, it designed Descartes-15 to be more resistant than Descartes-08 to recycling of the CAR upon multiple antigen exposures. It is developing Descartes-33 to deliver a combination of therapeutic proteins that target key drivers in the pathogenesis of autoimmunity. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.selectabio.com
본부
Wilmington, Delaware, USA
설립됨
-
Cartesian Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker RNAC. The last closing price for Cartesian Therapeutics was US$17.92. Over the last year, Cartesian Therapeutics shares have traded in a share price range of US$ 11.665 to US$ 41.87.

Cartesian Therapeutics currently has 25,414,898 shares in issue. The market capitalisation of Cartesian Therapeutics is US$455.43 million. Cartesian Therapeutics has a price to earnings ratio (PE ratio) of -2.04.

RNAC 최신 뉴스

추가 뉴스

Form 8-K - Current report
Edgar (US Regulatory)
03 3월 2025
RNAC (-0.39%)

Form 8-K - Current report
Edgar (US Regulatory)
27 1월 2025
RNAC (-0.39%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
14 1월 2025
RNAC (-0.39%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
14 1월 2025
RNAC (-0.39%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
14 1월 2025
RNAC (-0.39%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.24-1.3266998341618.0918.9717.138551217.84256216CS
4-1.55-7.9896907216519.42017.136853118.57143253CS
12-5.94-24.968474148823.7923.9316.49749918.61201627CS
263.584925.13056340314.265126.512.7710492319.265932CS
52-3.381-15.924826904121.23141.8711.66518530319.03184591CS
156-6.345-26.224426534424.19542.611.66533290222.56918998CS
260-6.345-26.224426534424.19542.611.66533290222.56918998CS

RNAC - Frequently Asked Questions (FAQ)

What is the current Cartesian Therapeutics share price?
The current share price of Cartesian Therapeutics is US$ 17.85
How many Cartesian Therapeutics shares are in issue?
Cartesian Therapeutics has 25,414,898 shares in issue
What is the market cap of Cartesian Therapeutics?
The market capitalisation of Cartesian Therapeutics is USD 455.43M
What is the 1 year trading range for Cartesian Therapeutics share price?
Cartesian Therapeutics has traded in the range of US$ 11.665 to US$ 41.87 during the past year
What is the PE ratio of Cartesian Therapeutics?
The price to earnings ratio of Cartesian Therapeutics is -2.04
What is the cash to sales ratio of Cartesian Therapeutics?
The cash to sales ratio of Cartesian Therapeutics is 17.27
What is the reporting currency for Cartesian Therapeutics?
Cartesian Therapeutics reports financial results in USD
What is the latest annual turnover for Cartesian Therapeutics?
The latest annual turnover of Cartesian Therapeutics is USD 26M
What is the latest annual profit for Cartesian Therapeutics?
The latest annual profit of Cartesian Therapeutics is USD -219.71M
What is the registered address of Cartesian Therapeutics?
The registered address for Cartesian Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Cartesian Therapeutics website address?
The website address for Cartesian Therapeutics is www.selectabio.com
Which industry sector does Cartesian Therapeutics operate in?
Cartesian Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
PSTVPlus Therapeutics Inc
US$ 1.46
(317.14%)
359.59M
AGMHAGM Group Holdings Inc
US$ 0.213
(108.21%)
694.71M
LZMHLZ Technology Holdings Ltd
US$ 9.79
(33.56%)
590.5k
TNXPTonix Pharmaceuticals Holding Corporation
US$ 14.62
(33.39%)
16.07M
GVVisionary Holdings Inc
US$ 4.89
(32.34%)
135.24M
BLNEEastside Distilling Inc
US$ 0.7846
(-89.40%)
12.25k
ACONAclarion Inc
US$ 1.5501
(-77.86%)
51.53M
ELABPMGC Holdings Inc
US$ 0.7132
(-42.02%)
1.51M
SNBRSleep Number Corporation
US$ 7.49
(-41.89%)
4.56M
CCLDCareCloud Inc
US$ 2.0904
(-33.00%)
1.23M
AGMHAGM Group Holdings Inc
US$ 0.213
(108.21%)
694.71M
PSTVPlus Therapeutics Inc
US$ 1.46
(317.14%)
359.59M
NVDANVIDIA Corporation
US$ 110.57
(-5.74%)
321.25M
GVVisionary Holdings Inc
US$ 4.89
(32.34%)
135.24M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10.75
(-11.38%)
134.95M

토론

전체 피드 보기
TheDane TheDane 2 분 전
It looks like the same playbook if not the same players.
GRRR
3331 3331 2 분 전
BIEL +20%, GOLDEN CROSS BREAKOUT, BLAST OFF!
3331 3331 3 분 전
BIEL +20%, GOLDEN CROSS BREAKOUT, BLAST OFF!
Jason2931 Jason2931 3 분 전
My psychic told me today $INQD is working on becoming current with PR's stacked. LB can only eat so many lazy dog meals before he must get back to work. Let's go INQD!
INQD
Truenorth2016 Truenorth2016 3 분 전
I showed you proof that this happens and it happens more than you think. Im not home right now but I will have more time to find the postings in which the QE×dn CEO took action on this stock manipulation on her stock
GCAN
Mr Smith 34 Mr Smith 34 3 분 전
The company financial reports for 12/31/2023 were prepared by William Tynan. He is the current, sole SPZI accountant who is singlehandedly running a multi-million dollar accounting department as well as being listed as working for several other OTC companies. Those 12/31/2023 reports had multiple d
SPZI
NASDAQ2020 NASDAQ2020 4 분 전
Put in I-box why.
TNXP
Involuntary-Recluse Involuntary-Recluse 4 분 전
OT

You think that Jimmy can still rock that riff on "Over under sideways down" or "Shape of things to come" ?
Some of those Yardbirds bootlegs featuring JP are absolute classics ;-)


imho
CLHI
3331 3331 4 분 전
BIEL: Vet RecoveryRx could be a gold mine in the multi-billion dollar US veterinarian pain market.

Vet RecoveryRx distributor for Europe:
https://vetphysiodevon.com/vet-recovery-rx#:~:text=An%20innovation%20in%20drug%2Dfree,energy%20to%20modulate%20nerve%20activity.
Lime Time Lime Time 5 분 전
That's the funniest thing I've read on iHub all day. You clearly must be joking. If not, I'm very sorry for you. Need some help brotha
3331 3331 5 분 전
BIEL: Vet RecoveryRx could be a gold mine in the multi-billion dollar US veterinarian pain market.

Vet RecoveryRx distributor for Europe:
https://vetphysiodevon.com/vet-recovery-rx#:~:text=An%20innovation%20in%20drug%2Dfree,energy%20to%20modulate%20nerve%20activity.
royal1 royal1 6 분 전
One hell of a wedding.
HMBL
XMaster2023 XMaster2023 6 분 전
Aspirin Might Be the Next Big Thing in Fighting the Spread of Cancer.

https://search.app/9z7qFC2ToH7dNywo7

Interesting…
NWBO
againstallodds againstallodds 6 분 전
Typo. Too challenged to figure it out
NBRI
ZenElf84 ZenElf84 8 분 전
Can't - Hasn't - or Won't?
If they are making their own PCBs, does that need to be patented? What specifically needs to be patented by a company to legitimize it?
Ring LLC has patents, but there are competitors in the market with similar products.

Hell - companies share
AITX
Involuntary-Recluse Involuntary-Recluse 8 분 전
I assume that Ben will advise when he submits the latest round of documents to the Judge.
Hopefully the judge expedites the next hearing so Ben can get this show on the road.

All will be forgiven/forgotten @ $2.48+++++++++++++ ;-)


IMHO
CLHI
3331 3331 9 분 전
BIEL: WORLDWIDE EXPANSION UNDERWAY!!!
New Zealand:
https://www.actipatch.nz/
Huge hit in Taiwan!
https://www.actipatchtw.com/general-1
Vet RecoveryRx/Europe:
https://vetphysiodevon.com/vet-recovery-rx#:~:text=An%20innovation%20in%20drug%2Dfree,energy%20to%20
Not likely Not likely 9 분 전
But he promised...

Surely that makes it legit.


What am I missing?
SPZI
3331 3331 9 분 전
BIEL: WORLDWIDE EXPANSION UNDERWAY!!!
New Zealand:
https://www.actipatch.nz/
Huge hit in Taiwan!
https://www.actipatchtw.com/general-1
Vet RecoveryRx/Europe:
https://vetphysiodevon.com/vet-recovery-rx#:~:text=An%20innovation%20in%20drug%2Dfree,energy%20to%20
littlejohn littlejohn 11 분 전
NVDA looks too cheap around 25 forward p/e

after a red day...

All the big shorts in democratic masks

are wanting market lower...

Other investors have money to buy cheap

stocks like NVDA now...

NVDA earnings and
AVGO NVDA SMCI
rx7171 rx7171 11 분 전
Isn’t this what the company did when they extended the AD Phase 2a/b into the Phase 2b/3 trial currently used as the basis for the EMA MAA?
AVXL
BDEZ BDEZ 12 분 전
Chuck Schumer estimated net worth $85 MILLION.
zab zab 12 분 전
Trump should resign, now, he can't handle the job of President. 

최근 히스토리

NASDAQ
RNAC
Cartesian Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지